Epsilon M&A Deal Report - Laboratoires Sarbec
Transaction Multiples for the Valuation of Private Companies
Groupe Vabel / Laboratoires Sarbec
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ||||||||
Current |
Multiple available | |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Personal Products » = 129
Date | Acquirer | Target | Country | Multiples | See details |
24/04/2020 | Orifarm Group | Takeda Pharmaceutical's OTC and prescription pharmaceutical products in Europe | Europe | ** | 113870 |
10/11/2020 | Cooper Consumer Health | Laboratoire Tradiphar | Nord | ** | 113842 |
Source: Epsilon Research / EMAT